196 related articles for article (PubMed ID: 9237865)
21. Macular pigment optical density and photophobia light threshold.
Wenzel AJ; Fuld K; Stringham JM; Curran-Celentano J
Vision Res; 2006 Dec; 46(28):4615-22. PubMed ID: 17087988
[TBL] [Abstract][Full Text] [Related]
22. Central retinal thickness is positively correlated with macular pigment optical density.
Liew SH; Gilbert CE; Spector TD; Mellerio J; Van Kuijk FJ; Beatty S; Fitzke F; Marshall J; Hammond CJ
Exp Eye Res; 2006 May; 82(5):915-20. PubMed ID: 16380117
[TBL] [Abstract][Full Text] [Related]
23. Nutritional manipulation of primate retinas, I: effects of lutein or zeaxanthin supplements on serum and macular pigment in xanthophyll-free rhesus monkeys.
Neuringer M; Sandstrom MM; Johnson EJ; Snodderly DM
Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):3234-43. PubMed ID: 15326146
[TBL] [Abstract][Full Text] [Related]
24. Supplementation with the carotenoids lutein or zeaxanthin improves human visual performance.
Kvansakul J; Rodriguez-Carmona M; Edgar DF; Barker FM; Köpcke W; Schalch W; Barbur JL
Ophthalmic Physiol Opt; 2006 Jul; 26(4):362-71. PubMed ID: 16792735
[TBL] [Abstract][Full Text] [Related]
25. Macular telangiectasia: patterns of distribution of macular pigment and response to supplementation.
Zeimer MB; Krömer I; Spital G; Lommatzsch A; Pauleikhoff D
Retina; 2010 Sep; 30(8):1282-93. PubMed ID: 20671587
[TBL] [Abstract][Full Text] [Related]
26. On the age dependency of the macular pigment optical density.
Berendschot TT; van Norren D
Exp Eye Res; 2005 Nov; 81(5):602-9. PubMed ID: 16024015
[TBL] [Abstract][Full Text] [Related]
27. Macular pigment and visual performance under glare conditions.
Stringham JM; Hammond BR
Optom Vis Sci; 2008 Feb; 85(2):82-8. PubMed ID: 18296924
[TBL] [Abstract][Full Text] [Related]
28. Assessment of macular pigment optical density (MPOD) in patients with unilateral wet age-related macular degeneration (AMD).
Tsika C; Tsilimbaris MK; Makridaki M; Kontadakis G; Plainis S; Moschandreas J
Acta Ophthalmol; 2011 Nov; 89(7):e573-8. PubMed ID: 21672183
[TBL] [Abstract][Full Text] [Related]
29. Macular pigment in the human retina: histological evaluation of localization and distribution.
Trieschmann M; van Kuijk FJ; Alexander R; Hermans P; Luthert P; Bird AC; Pauleikhoff D
Eye (Lond); 2008 Jan; 22(1):132-7. PubMed ID: 17401321
[TBL] [Abstract][Full Text] [Related]
30. Macular carotenoid levels of normal subjects and age-related maculopathy patients in a Japanese population.
Obana A; Hiramitsu T; Gohto Y; Ohira A; Mizuno S; Hirano T; Bernstein PS; Fujii H; Iseki K; Tanito M; Hotta Y
Ophthalmology; 2008 Jan; 115(1):147-57. PubMed ID: 18166409
[TBL] [Abstract][Full Text] [Related]
31. Dose-dependent response of serum lutein and macular pigment optical density to supplementation with lutein esters.
Bone RA; Landrum JT
Arch Biochem Biophys; 2010 Dec; 504(1):50-5. PubMed ID: 20599660
[TBL] [Abstract][Full Text] [Related]
32. Spinach cultigen variation for tissue carotenoid concentrations influences human serum carotenoid levels and macular pigment optical density following a 12-week dietary intervention.
Kopsell DA; Lefsrud MG; Kopsell DE; Wenzel AJ; Gerweck C; Curran-Celentano J
J Agric Food Chem; 2006 Oct; 54(21):7998-8005. PubMed ID: 17032001
[TBL] [Abstract][Full Text] [Related]
33. A practical method for measuring macular pigment optical density.
Wooten BR; Hammond BR; Land RI; Snodderly DM
Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2481-9. PubMed ID: 10509640
[TBL] [Abstract][Full Text] [Related]
34. Abnormal macular pigment distribution in type 2 idiopathic macular telangiectasia.
Helb HM; Charbel Issa P; VAN DER Veen RL; Berendschot TT; Scholl HP; Holz FG
Retina; 2008 Jun; 28(6):808-16. PubMed ID: 18536596
[TBL] [Abstract][Full Text] [Related]
35. Color matching in diabetes: optical density of the crystalline lens and macular pigments.
Davies NP; Morland AB
Invest Ophthalmol Vis Sci; 2002 Jan; 43(1):281-9. PubMed ID: 11773043
[TBL] [Abstract][Full Text] [Related]
36. Nutritional manipulation of primate retinas. IV. Effects of n--3 fatty acids, lutein, and zeaxanthin on S-cones and rods in the foveal region.
Leung IY; Sandstrom MM; Zucker CL; Neuringer M; Max Snodderly D
Exp Eye Res; 2005 Nov; 81(5):513-29. PubMed ID: 15916761
[TBL] [Abstract][Full Text] [Related]
37. Association of macular pigment optical density with serum concentration of oxidized low-density lipoprotein in healthy adults.
Nagai N; Izumi-Nagai K; Suzuki M; Shinoda H; Koto T; Uchida A; Mochimaru H; Tomita Y; Miyake S; Kobayashi S; Sasaki M; Tsubota K; Ozawa Y
Retina; 2015 Apr; 35(4):820-6. PubMed ID: 25473786
[TBL] [Abstract][Full Text] [Related]
38. Macular zeaxanthins and lutein -- a review of dietary sources and bioavailability and some relationships with macular pigment optical density and age-related macular disease.
Thurnham DI
Nutr Res Rev; 2007 Dec; 20(2):163-79. PubMed ID: 19079868
[TBL] [Abstract][Full Text] [Related]
39. The effects of supplementation with lutein and/or zeaxanthin on human macular pigment density and colour vision.
Rodriguez-Carmona M; Kvansakul J; Harlow JA; Köpcke W; Schalch W; Barbur JL
Ophthalmic Physiol Opt; 2006 Mar; 26(2):137-47. PubMed ID: 16460314
[TBL] [Abstract][Full Text] [Related]
40. Macular pigment in donor eyes with and without AMD: a case-control study.
Bone RA; Landrum JT; Mayne ST; Gomez CM; Tibor SE; Twaroska EE
Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):235-40. PubMed ID: 11133874
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
